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Abstract
During spermatogenesis, extensive restructuring takes place at
the Sertoli–Sertoli and Sertoli–germ cell interface, which is
regulated via intriguing interactions among cytokines,
proteases, protease inhibitors, kinases, phosphatases, and
transcription factors. This in turn determines the steady-state
levels of integral membrane proteins at the cell junctions.
We sought to further expand these observations using the
Adjudin model. Adjudin is a potential male contraceptive that
targets Sertoli–germ cell adhesion, causing exfoliation of
spermatids and spermatocytes, but not spermatogonia, from
the seminiferous epithelium. This model thus provides the
means to identify crucial regulatory molecules and signaling
pathways pertinent to junction restructuring events during
spermatogenesis. In this study, genome-wide expression
profiling of rat testes after treatment with Adjudin at the
time of extensive junction restructuring was performed.
Differentially regulated genes, such as cytokines, proteases,
protease inhibitors, cell junction-associated proteins, and
transcription factors pertinent to junction restructuring were
identified. These data were consistent with earlier findings;
however, much new information was obtained which has been
deposited at the Gene Expression Omnibus data repository
website: http://www.ncbi.nih.gov/geo/ with Accession
number: GSE5131. The primary signaling events pertinent
to junction restructuring in the testis induced by Adjudin were
also delineated using bioinformatics. These findings were also
consistent with recently published reports. The identified
molecular signatures or targets pertinent to junction dynamics
in the testis as reported herein, many of which have not been
investigated, thus offer a framework upon which the regulation
of junction restructuring events at the Sertoli–Sertoli and
Sertoli–germ cell interface pertinent to spermatogenesis can be
further studied.
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Introduction
In adult rat testes, spermatogonia (diploid, 2n) divide and
differentiate into spermatids (haploid, 1n) while traversing
the seminiferous epithelium from the basal to the apical
compartment, reaching the luminal edge of the seminiferous
epithelium to permit spermiation that occurs at stage VIII of
the epithelial cycle. For spermatogonia to become fully
developed elongate spermatids (i.e. spermatozoa) takes
w58 days in rats and spansw4.5 rounds of the seminiferous
epithelial cycle (w12–14 days per cycle in rats) with each
cycle comprising 14 distinct stages that display unique
association between Sertoli and germ cells at different
developmental stages (Parvinen 1982, de Kretser & Kerr
1994). Thus, extensive restructuring at the Sertoli–Sertoli
and Sertoli–germ cell interface is taking place in the
seminiferous epithelium during spermatogenesis (Cheng &
Mruk 2002, Mruk & Cheng 2004b). Since different germ
cells are arranged into layers across the epithelium and
progressively migrate toward the seminiferous tubule lumen,
their interactions with Sertoli cells also differ spatially
(Russell 1977). It is well established that spermatogenesis is
regulated by follicle-stimulating hormone (FSH) and
testosterone under the influence of the hypothalamic–
pituitary–testicular axis (de Kretser & Kerr 1994, Eddy
1998). However, crosstalk between Sertoli and germ cells in
the seminiferous epithelium and their regulation pertinent to
spermatogenesis and spermiogenesis remain largely unex-
plored. Recent studies have shown that the intriguing events
of Sertoli–germ cell interactions at the cell–cell interface are
regulated by cytokines (e.g. transforming growth factor
(TGF)-b3 and tumour necrosis factor (TNF)a) that work in
concert with proteases, protease inhibitors, kinases, and
phosphatases in the microenvironment of the seminiferous
epithelium behind the basement membrane. The collective
interactions of these molecules determine the timely
‘opening’ and ‘closing’ of the blood–testis barrier (BTB) to
facilitate preleptotene spermatocyte migration across the
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barrier and germ cell movement during the epithelial cycle
(Mruk & Cheng 2004b). Additionally, supporting evidence
for this local regulatory mechanism is derived from germ cell
transplantation studies showing that rat spermatogonia
injected into seminiferous tubules in mice differentiate
independent of the surrounding milieu (for reviews, see
McLean et al. 2001 and Matzuk 2004).
Adjudin [1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohy-
drazide], formerly known as AF-2364, is a molecule that
mediates adherens junction disruption at the Sertoli–germ
cell interface (Mruk & Cheng 2004b). It is a derivative of
lonidamine having a more potent aspermatogenic activity
but less toxicity versus lonidamine (Cheng et al. 2001, Grima
et al. 2001). When administered to adult rats by gavage,
Adjudin exerts its effects primarily at the Sertoli–germ cell
interface, causing germ cell sloughing, in particular
elongating/elongate/round spermatids and spermatocytes
from the epithelium without perturbing adhesion between
spermatogonia and Sertoli cells; as such, its effects are
reversible (Mruk & Cheng 2004b, Cheng et al. 2005). Based
on these initial observations, Adjudin has been used to
develop an in vivo model to characterize cell–cell interactions
and junction dynamics pertinent to spermatogenesis (Siu
et al. 2003b, 2005, Lee & Cheng 2005, Xia & Cheng 2005,
Yan & Cheng 2005, Xia et al. 2006). For instance, the
integrin/focal adhesion kinase (FAK)/phosphatidylinositol
3-kinase (PI-3) kinase/extracellular signal regulated kinase
(ERK) signaling pathway was shown to regulate Sertoli–
germ cell adherens junction (AJ) dynamics, particularly the
apical ectoplasmic specialization (ES), using Adjudin-treated
rat testes (Siu et al. 2003b, 2005). Furthermore, a loss of
protein–protein interactions between integral membrane
proteins and their adaptors at the AJ (e.g. apical and basal
ES) to facilitate AJ and BTB restructuring were also detected
using this model (Lee et al. 2005, Xia & Cheng 2005). This
signal pathway activation and the loss of protein–adaptor
interactions at the AJ were also demonstrated during
spermatid loss from the epithelium, which was induced by
suppressing intratesticular androgen level using testosterone
and estrogen implants in adult rats (Wong et al. 2005, Xia
et al. 2005b, Zhang et al. 2005). Collectively, these data
clearly illustrate that the Adjudin model is a valuable tool to
identify signaling pathways pertinent to AJ dynamics and
possibly the regulatory mechanisms pertinent to spermato-
genesis. Since DNA microarray technique has been widely
used to unravel global transcriptional changes (for a review,
see Stoughton 2005), we sought to identify these potential
regulators of junction remodeling pertinent to spermatogen-
esis using expression microarray. In this report, we describe
findings based on the use of Affymetrix Genechips (rat
genome) that containw30 000 probe sets to characterize the
expression profile in rat testes following treatment with
Adjudin at the time of AJ restructuring. The genes and the
signaling conduits identified by microarray could provide a
framework to further probe the biological processes of
junction restructuring pertinent to spermatogenesis.
Materials and Methods
Animals and microarray gene chips
Male Sprague–Dawley rats (w300 g b.w.) were purchased
from Charles River Laboratories (Kingston, MA, USA). The
use of animals in this study was approved by The Rockefeller
University Animal Care and Use Committee, with protocol
numbers 03017 and 06018. Rats were treated with a single
dose of Adjudin at time 0 by gavage at 50 mg/kg body weight
(b.w.) as described earlier (Cheng et al. 2001, Grima et al.
2001). For microarray analysis, rats (nZ3 for time 0 and 96 h;
nZ2 for 8 h) were killed by CO2 asphyxiation. These two
time points were selected since by 8 h, even though some
elongate and elongating spermatids had begun to exfoliate
from the seminiferous epithelium, most germ cells remained
attached to Sertoli cells in the seminiferous epithelium. Even
for those that were detached from the epithelium, they were
still found in the tubule lumen. As such, this is the time that
extensive AJ restructuring was occurring at the Sertoli–germ
cell interface, but germ cells remained in the samples being
analyzed by microarray. By day 4, virtually all elongating/
elongate spermatids were depleted from the epithelium and
most round spermatids and spermatocytes had left the
epithelium and tubule lumen as well, suggesting the induced
AJ restructuring had subsided as shown in earlier studies
(Chen et al. 2003, Mruk & Cheng 2004a,b). Testes were
frozen immediately in liquid nitrogen upon termination and
stored atK80 8C until use for RNA extraction. Rat Genome
230 2.0 GeneChips were purchased from Affymetrix, Inc.
(Santa Clara, CA, USA) and used for this study.
Total RNA preparation
About 0.1 g testis from each sample was used for total RNA
isolation using TRIZOL (Invitrogen). RNA was then
purified with an RNeasy cleanup kit (Qiagen). Total RNA
quality was assessed with an Agilent 2100 Bioanalyzer
(Agilent Technologies, Palo Alto, CA, USA).
cRNA labeling, hybridization, and array scanning
cDNA synthesis and cRNA labeling by in vitro transcription
(IVT) were performed using GeneChip One-Cycle Target
Labeling and Control Reagents (Affymetrix, P/N 900493).
Briefly, total RNA (w5 mg) prepared as mentioned above
was first reverse transcribed using a T7-oligo (dT) promoter
primer in the first-strand cDNA synthesis reaction.
Following RNase H-mediated second-strand cDNA
synthesis, the double-stranded cDNA was purified and
served as a template in the subsequent in vitro transcription
reaction. The IVT reaction was carried out in the presence
of T7 RNA polymerase and a biotinylated nucleotide
analog/ribonucleotide mix for cRNA amplification and
biotinylation following the protocols provided by the
manufacturer. The biotinylated cRNA targets were then
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purified using RNeasy spin columns, and fragmented at
94 8C for 35 min in a fragmentation buffer (40 mM Tris-
acetate (pH 8.1) containing 100 mM potassium acetate and
30 mM magnesium acetate), which were used for hybrid-
ization with GeneChips. The integrity of the labeled cRNA
was again assessed by Agilent 2100 Bioanalyzer before
hybridization. The GeneChip Fluidics Station 450 was used
for array hybridization and processing and the Affymetrix
GeneChip Scanner 3000 for array scanning. cRNA labeling,
hybridization, and array scanning were performed at
The Rockefeller University Genomics Resource Center
(New york, NY, USA). The experiment was repeated twice
using different samples.
Microarray data analysis
Scanned images of the microarray were first visually examined
to rule out physical anomalies or excessive high background.
Data were initially accessed using the Microarray Suite 5.0
(MAS) software (Affymetrix) and all probe sets on each array
were scaled to a target signal intensity of 250. This prescaling
assured data uniformity in subsequent cross-chip comparison.
MAS assessment also reported the background noise, the
number of probe sets that are present, marginal, or absent in
the samples out of a total of 31 099 probe sets on Rat Genome
230 2.0 GeneChip based on signals. Data were then exported
and analyzed using the GeneSpring software (Version 7.2,
Agilent). All samples were grouped accordingly into time 0
(control), 8-h and 4-day post-Adjudin treatment. Data were
normalized in three steps: step 1, data transformation to set
measurements from !0.01 to 0.01. Step 2, per chip
normalization to the median or 50th percentile intensity of
the probe set in each chip to remove non-biological variations
such as differences in the experiment conditions. Step 3, per
gene normalization to normalize all samples to time 0 (the
median value for each probe set among the three control
samples was used). Data were further filtered using the
filtering on flags feature (namely signal detection, present,
marginal or absent; at least present or marginal in one of the
sample after Adjudin treatment) in Genespring to identify
genes that are expressed in one of the experimental conditions
under study (e.g. Adjudin treatment) and expression raw
value (at least 50) to remove unreliable genes. Thereafter,
genes that were expressed differentially and were statistically
significantly different from control (normal rat testes, P!
0.05) were determined by one-way ANOVA for multiple
comparisons between samples in control (nZ3) and treatment
groups (nZ2 for 8 h or nZ3 for 4-day post-Adjudin
treatment) with multiple test correction (default option) and
multiple test correction set to ‘none’, using the Agilent
GeneSpring software. Genes with significant changes in
their steady-state mRNA levels in comparison with control
were scored and grouped. Hierarchical clustering analysis
(unsupervised) was performed in the GeneSpring software
using default settings. Gene ontology and signaling pathway
analysis was performed using Onto Express and Pathway
Express programs available from Wayne State University
(Draghici et al. 2003a,b, Khatri et al. 2004, 2005). The
Affymetrix probe set ID corresponding to the specific gene at
the GeneBank database with fold changes in the steady state
mRNA levels at 8 h or at day 4 were imported into the
programs and the top-ranking pathways were identified.
Quantitative real-time RT-PCR and data analysis
To validate relative expression levels of selected genes from
microarray studies, quantitative real-time RT-PCR (qPCR) was
performed using an Applied Biosystems Prism 7700 Sequence
DetectionSystemwithSYBRGreenPCRMasterMix (Applied
Biosystems, Inc., Foster City, CA, USA). Primers for qPCR
were designed using either the Oligonucleotide Properties
Calculator at www.basic.northwestern.edu/biotools/oligocalc.
html or the Primer Express (Version 2.0) from Applied
Biosystems, Inc. and were compared with the existing database
at GenBank using the basic local alignment search tool (BLAST)
to ensure specificity (see Table 1). Briefly, total RNA from
different samples were prepared using TRIZOL (Invitrogen) and
treated with DNaseI (Invitrogen) to remove contaminating
genomic DNA before reverse transcription. Equal amount of
total RNA was then reverse transcribed using Moloney murine
leukemia virus reverse transcriptase (M-MLV RT, Promega)
with 2 mg RNA in a 25 ml reaction. Both primers (5 pmol each)
Table 1 Gene-specific primers for real-time RT-PCR
Genbank accession
number Forward primer (sense, 5 0–3 0) Reverse primer (antisense, 5 0–3 0) Product length (bp)
Target gene
Bhlhb2 NM_053328 5 0-CCCACCCTTCTCCTTTATTGTG 5 0-TACCGAGACATGCCAGTGTTG 106
c-fos X06769 5 0-TTCTCAATGACCCTGAGCCCA 5 0-TGCCGGAAACAAGAAGTCATC 101
Cxcl10 BC058444 5 0-TCCCTGTTTCTCCTGACCATG 5 0-AGCCTTGCTGCTGGAGTTACT 101
IL-1a NM_017019 5 0-TTCCTCGTCCTAAGTCACTCGC 5 0-TGGTTCCACTAGGCTTTGCTCT 101
Jun NM_021835 5 0-CCTTGAAAGCGCAAAACTCC 5 0-CCCACTGTTAACGTGGTTCATG 101
Prss11 BC081767 5 0-TAACACCTTGAAGGTGACGGC 5 0-TTTTCCCTTTGGCCTGTCGA 101
Serping1 NM_199093 5 0-TGAAGACATGGAAAAGGCACTC 5 0-TGCGAGGCATCATCACGTAA 101
Stat3 NM_012747 5 0-TCCCCCCGCACTTTAGATTCA 5 0-TCCATGTCAAACGTGAGCGAC 101
Tnfrsf1a NM_013091 5 0-TGCCACGCAGGATTCTTTCT 5 0-TTTGCAACTGGAGGTAGGCAC 101
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and various templates (serially diluted control testis cDNA for
generating the standard curve, and 1 ml Reverse transcription
product from all samples) were mixed with 2!SYBR Green
PCR Master Mix in a 25 ml final reaction volume. The thermal
cycler conditions were 10 min at 95 8C, followed by two-step
(15 s at 95 8C and 1 min at 60 8C) PCR for 40 cycles, and a slow
heating up to 95 8C for dissociation analysis at the end to ensure
the purityof the PCR product. Amplification datawere analyzed
with an Applied Biosystems Prism Sequence DetectionSoftware
(Version 2.1). The cycle threshold (CT) value corresponding to
the PCR cycle number at which fluorescence emission in real
time reached a threshold above the baseline emission was
determined. The CT value for each sample was then exported
and analyzed in Microsoft Excel. A combination of standard
curve and comparative CT methods were applied for the analysis
(User Bulletin #2 ABI PRISM 7700 Sequence Detection
System, Applied Biosystems). For standard curve method, CT for
Stat3 and S-16 were plotted as CT value against logarithm of
relative input RNA amount respectively, and then the input
RNA amount for each sample was calculated based on its CT
value in reference to the corresponding standard curve. Relative
expression of Stat3 was normalized to the S-16 control for each
sample. For comparative CT method, the difference of CT
between the target gene and S-16 for each sample was calculated
(DCT) and then this difference for other samples was compared
with that of a particular sample (DDCT). The expression level
in any sample relative to that particular sample was given by
2KDDCT. All reactions were prepared in triplicate and three
independent sets of samples were used in each experiment.
Results of qPCR were analyzed by one-way ANOVA for
multiple comparisons using the JMP IN statistical analysis
software package (Version 4, SAS, Inc., Cary, NC, USA).
Immunohistochemistry and immunoblot analysis
Immunohistochemistry (IHC) for selected genes was
performed essentially as previously described (Xia & Cheng
2005). Antibodies used in this study were either raised in this
laboratory (rabbit anti-testin (Cheng & Bardin 1987), anti-
cathepsin L (Lee et al. 1986), a2-MG (Cheng et al. 1990)) or
purchased from Zymed-Invitrogen (Carlsbad, CA, USA)
(rabbit anti-claudin 3 polyclonal antibody). Immunoblot
analysis was performed as described earlier (Xia & Cheng
2005). Testis lysates from samples were prepared and resolved
by SDS-PAGE and probed against a panel of antibodies.
Assessing changes in the steady-state mRNA levels of target genes
in testes taking into account cellular composition alteration in the
seminiferous epithelium following Adjudin treatment – a
mathematical model
Adjudin treatment induces massive germ cell depletion from the
seminiferous epithelium, with initial loss of elongating/elongate
spermatids, to be followed by round spermatids and sperma-
tocytes (Chen et al. 2003; Fig. 1A–C). As such, the cellular
composition in the epithelium changes with time following
treatment, particularly between days 1 and 4, during germ cell
sloughing. For instance, if a protein is exclusively expressed by
Sertoli cells, such as occludin, its induction that was detected by
RT-PCR and/or immunoblotting following Adjudin treat-
ment versus controls by day 4 may simply reflect an increase in
cellular RNAs or proteins contributed by Sertoli cells in the
samples being analyzed because of declining germ cell numbers
as a result of germ cell loss. This thus makes it difficult to assess if
induction of a target protein is in fact related to junction
restructuring or the result of cellular composition alteration.
Herein, we provide a mathematical model to relate changes in
cellular composition and an alteration of expression level of a
target protein/gene so as to provide a threshold by which one
can accept or reject data generated in this Adjudin or similar
animal models. Because non-germ cell types in the testis (e.g.
Sertoli, Leydig, and myoid cells) do not have any significant
changes after Adjudin treatment (Cheng et al. 2001, 2005,
Grima et al. 2001), we collectively assigned these cell types as
somatic cells and categorized them under the Sertoli cell item as
an entity. We also did not discriminate germ cells at different
Figure 1 Morphological analysis of testes after Adjudin treatment and a summary of the gene expression profiles in testes at the time of
extensive junction restructuring at the Sertoli–germ cell interface. (A; a–c). Paraffin sections of testes stained with hematoxylin in normal (Ctrl)
rats (a) versus 8 h (b) and day 4 (c) after Adjudin treatment, spermatids were still loosely attached to Sertoli cells in the seminiferous epithelium
by 8 h (b) post-treatment even though elongating spermatids and spermatocytes were found in lumen of most tubules examined versus day 4
(c), when virtually all spermatids were depleted from the epithelium ,and control (Ctrl, normal) testes. Bar in aZ40 mm which applies to
(b and c); bar in inset in aZ150 mm, which applies to insets in (b and c). (d) Changes in testis weight (per organ pair) after Adjudin treatment as
a result of germ cell loss (nZ5). Percentage of testis weight in comparison with control (Ctrl, normal rats) testes was also annotated. ns, Not
significantly different from control (normal) rats by ANOVA; *P!0.01. (e) Each of the total of 31 099 probe sets on the Affymetrix GeneChip
Rat Genome 230 2.0 array, was assigned a Flag to indicate its presence (P), marginal (M), or absence (A) based on the signal detected.
The solid bar summarized the mean percentage of genes in each of the three groups from a total of eight samples (nZ3 for control testes, nZ2
for 8 h and nZ3 for 4 days after Adjudin treatment). All the raw microarray data have been deposited at the Gene Expression Omnibus (GEO)
data repository website: http://www.ncbi.nih.gov/geo/ with the accession number: GSE5131. (f and g) Normalized expression level of each
gene at 8 h or at day 4 was plotted against its raw expression level (signal intensity) in control (Ctrl) testes. Each dot is a mean of data from two
(8 h) or three (Ctrl and day 4) gene chips using different samples for hybridization. The two green lines above and below the green line marked
at 1 represent a twofold change, namely induction or suppression, in gene expression level versus control. The color scheme (red signifies an
increased expression and blue decreased expression) shown herein is the same as in Fig. 4A. (B) Venn diagram summarizing the number of
genes with at least twofold changes in expression levels at 8 h and at day 4 from a total of 1466 transcripts that were found to be differentially
regulated by one-way ANOVA.
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developmental stages and categorized them under the ‘germ
cell’ as an entity. This model was being used to screen target
proteins/genes that are pertinent to junction restructuring
by accepting their induction in the microarray experiments
as physiologically relevant.
We assume the testis weight before Adjudin treatment to be
1 and after treatment to be m, m!1.
Control ðnormalÞ testis status ðAÞ is : pCqZ 1
Testis status after Adjudin treatment ðBÞ is : p0Cq0Zm
where p, p 0 are the corresponding Sertoli cell fractions before
and after Adjudin treatment, and q, q 0 are the corresponding
germ cell fractions before and after Adjudin treatment
(assuming pZp 0 since Sertoli cells were not affected by
Adjudin; and 0!p%m!1, 0!q 0%m, qOq 0).
For a target gene of interest, such as Z, its expression level
in A (total) is:
ZAZ paCqb;
and Z expression level in B (total) is:
ZBZ p
0a0Cq0b0Z pa0Cqb0
where a, a 0 are the corresponding expression coefficients for
gene Z in Sertoli cells before and after Adjudin treatment in A
or B, and b, b 0 are the corresponding expression coefficients
for gene Z in germ cells and after Adjudin treatment in A or B
with 0%a, a 0, b, b 0. The expression coefficient of a target
gene is the total number of copies of gene Z mRNA in Sertoli
(a) or germ (b) cells. For instance, in normal testes occludin is
expressed in Sertoli cells only. Therefore, aoccludin is a positive
value and boccludinZ0 (note: the exact value for aoccludin is not
required for the following calculations, see below).
From the microarray experiments, changes in the expression
level of a target gene Z for testis status B versus control status A
were determined as x. Because the same amount of total RNA
has used in treatment versus control samples, i.e. from the same
unit weight of testis tissue (assuming the same unit weight of
tissue from different samples contain the same amount of total
RNA), the following formula was used:
ZB=ZAZ ðpa0Cqb0Þ=ðpaCqbÞZ ðx=1Þ!ðm=1Þ
Z xm=1!1Zmx
We consider the following three possibilities regarding target
gene/protein changes during Adjudin-induced germ cell loss
from the seminiferous epithelium:
1. If gene Z is only expressed in Sertoli cells: bZ0, b0Z0.
Thus, ZB/ZAZa
0/aZmx. For example, 4 days after Adjudin
treatment, m (weight of testis versus control)Z0.73 (see
Fig. 1Ad), then if a0/aO1, x should be O1/0.73/xR1.4.
This indicates only those genes withR1.4-fold of change are
considered to be induced in the testis after Adjudin treatment.
We set the threshold xR2, thusa0/aZmxR0.73!2z1.5. For
genes listed in Table 4, the threshold is actually xR4 by day 4,
meaning a0/aR0.73!4z3.
2. If gene Z is only expressed in germ cells: aZ0, a0Z0
Thus;
ZB
ZA
Z
ðq0b0Þ
ðqbÞ Zmx/
b0
b
Zmx
q
q0Zmx
ð1KpÞ
ðmKpÞ
Z x
ðmKmpÞ
ðmKpÞ Ox
(since m!1).
In this case, the actual fold changes in gene induction in
germ cells are greater than the reported fold of changes for x.
3. If gene Z is expressed in both Sertoli and germ cells:
ZB
ZA
Z
ðpa0Cq0b0Þ
ðpaCqbÞ Zmx
Herein,
min ðpa0Þ=ðpaÞ; ðq0b0Þ=ðqbÞ % ðpa0Cq0b0Þ=ðpaCqbÞ
%max ðpa0Þ=ðpaÞ; ðq0b0Þ=qbÞ 
where min [(pa0)/(pa), (q0b0)/(qb)] is the minimal value of the
two and max[(pa0)/(pa), (q0b0)/(qb)] is the maximal value of the
two (this is because pa0, q0b0, pa and qb are all positive values.
When a, b, c, dO0, (a/c)%(b/d), then (a/c)%(aCb)/(cCd)
%(b/d). Therefore, either (pa0)/(pa)Rmx or (q0b0)/(qb)Rmx.
When we select the threshold for x such that mxR1 (at
day 4, xR2 and mxR1.46), then either pa 0/paRmxO1
(/a 0/aR1, i.e. induction in Sertoli cells) or q 0b 0/qbRmxO1
(/b 0/bRq/q 0O1, i.e. induction in germ cells). On the other
hand, the possibility in (3) can be treated as a mixture of (1) and
(2), and on average, ZB/ZA should be between the values in (1)
and (2) as well. Whichever the possibility, the threshold xR2
translates into a minimal 1.5-fold induction in either germ or
Sertoli cells. Table 4 lists those target genes with fourfold of
induction (xR4) by day 4 showing Adjudin treatment, which
translates into a minimal threefold of induction in either germ
or Sertoli cells.
We selected target gene Myd116 for the sake of discussion,
which was shown to be induced 3.5-fold at 8 h and 1.7-fold
at day 4 (see Table 3). At 8 h, 3.5!0.9Z3.15 and at day 4,
1.7!0.73Z1.241. These results indicate that (1) if this gene
is exclusively expressed in Sertoli cells (case 1), there was a
3.15-fold induction at 8 h (significant) and only 1.241-fold
induction at day 4 (not likely to be significant); (2) if this gene
is exclusively expressed in germ cells (case 2), there was more
than 3.5-fold induction at 8 h (significant) and more than 1.7-
fold induction at day 4 (not certain); (3) if this gene is
expressed both in Sertoli and germ cells (case 3), there was an
overall 3.15- to 3.5-fold induction at 8 h (significant) and
1.241- to 1.7-fold induction at day 4 (not certain).
Collectively, this gene is significantly induced at 8 h and not
likely to be induced significantly at day 4 under all
possibilities. Thus, the twofold threshold is a reliable filter
to accept or reject any data to assess if a target gene has been
induced. Nonetheless, additional cautious steps have to be
taken since these data should be validated by techniques of
IHC, fluorescent microscopy, and immunoblottings.
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Results
Microarray data deposition
The original data sets generated in this report have been
deposited at the Gene Expression Omnibus (GEO) data
repository website: http://www.ncbi.nih.gov/geo/ with
accession number: GSE5131.
Adjudin-induced morphological changes in adult rat testes
The rationale of selecting the 8-h and 4-day time points post-
Adjudin treatment for their comparison with control (normal
testes) was based on an earlier report that investigated the
kinetics of germ cell loss from the epithelium (Chen et al. 2003).
By 8 h after Adjudin treatment, while more than half of the
seminiferous tubules examined (nZ600 from four testes with
w125 tubules randomly scored per testis) displayed signs of
germ cell loss withR10 elongating/elongate spermatids found
in tubule lumen, most elongating spermatids, round spermatids,
and spermatocytes still remained attached to Sertoli cells in the
epithelium (see Fig. 1Ab vs Fig. 1Aa). This observation also
illustrates that even though there was extensive restructuring at
the Sertoli–germ cell interface and depleting elongating/
elongate spermatids were found in the lumen, the cellular
composition as well as RNAs contributed by Sertoli and germ
cells in the samples being analyzed by microarrayswere similar to
control testes. This argument is supported by the finding that
only aw10% decline, which was not statistically significant, in
testicular weight was detected by 8 h (see Fig. 1Ad). By 4 days
after Adjudin treatment, about 80% of the tubules that were
scored were shown to have the number of round spermatid
layers reduced by twofold or more with virtually all elongating/
elongate spermatids depleted from the epithelium, and most of
the tubules were only populated with round spermatids,
spermatocytes, and spermatogonia along with Sertoli cells
(Chen et al. 2003; Fig. 1Ac vs Fig. 1Aa, and b).These results were
consistentwith a significant loss of testicular weight, byw27% at
day 4 (Fig. 1Ad). Due to the changes in cellular composition in
the tubules as a result of progressive germ cell loss, we sought to
correct the expression levels of genes detected by microarray
studies by normalizing the results by the testis weight loss since
totalRNAfromwhole testeswasused for microarrayanalysis. In
our analysis, a threshold was set at twofold, which translated into
w1.5-fold of net changes (2!73%) for 4-day samples and
w1.8-fold of net changes (2!90%) for 8-h samples, so as to set
the basis to ‘accept’ that a target gene had been ‘induced’
following Adjudin treatment. A detailed quantitative mathe-
matical analysis of gene expression/protein level changes in
concert with cellular composition alteration in the seminiferous
epithelium is described in Materials and Methods. Based on this
analysis, a twofold induction of a target gene/protein expression
has exceeded the threshold that could be simply accounted for
by cellular composition alterations in the epithelium by 8 h
4-day post Adjudin treatment, which would translate into, at the
maximum, a 1.5-fold change for a target gene. As such, the focus
of this study was placed on genes that were induced by twofold
or more in particular by day 4. As expected, many genes
appeared to be down-regulated in 4-day samples when most
germ cells were depleted from the epithelium, illustrating that
these genes were exclusively or abundantly expressed by germ
cells. As such, these data (see Supplementary Table 1 and raw
data deposited at GEO website), also offer the means to identify
germ cell-specific genes.
Assessment of microarray data
The Affymetrix GeneChip uses external RNA controls, also
known as spikes, or spike-in controls, to assess the inter-
microarray experimental variations (Bakel & Holstege 2004,
Stoughton 2005). Statistical analysis was performed by
comparing data obtained from normal (control) rat testes
versus treatment groups by one-way ANOVA for multiple
comparisons with multiple test correction (default option),
and multiple test correction was set to ‘none’ using the
GeneSpring software (see Materials and Methods). The signals
for these controls, as well as for housekeeping genes (e.g.
glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) and
b-actin) were consistent between chips (i.e. between different
samples) in a single experiment, and were also consistent
between samples from different experiments. For testis samples
from control rats (nZ3) and 8 h (nZ2) after Adjudin
treatment, about 55% of 31 099 probe sets were positively
detected (i.e. present), about 500 (w1.6%) were absent and
44% probe sets were detected as marginal, (Fig. 1Ae).
However, samples from rats on day 4 (4 days, nZ3) after
Adjudin treatment have shown an increase in the number of
genes present (w59%), and a reduction in the number of genes
marginal (w40%), whereas the number of genes that were
absent remained unchanged atw1.6% (Fig. 1Ae). These results
indicated that w4% of genes in the rat genome or w1240
probe sets became detectable following a longer period of
Adjudin treatment (by day 4) and when the epithelium was
devoid of virtually all elongating/elongate spermatids, and
w40–50% round spermatids and w10–20% spermatocytes
(see Fig. 1A). Indeed, an examination of all probe sets by
plotting the normalized expression levels at 8 h or at day 4
versus their corresponding raw expression levels or signal
intensities in control samples revealed a more dispersed
distribution for day 4 than 8 h (Fig. 1Af vs g). In particular,
there were more probe sets at day 4 than at 8 h that fell above or
below the twofold threshold lines with signal intensitiesO100,
indicating more genes were differentially regulated at the later
time point after Adjudin treatment. We filtered out 1466
transcripts which were significantly regulated after Adjudin
treatment (control, 8 h and day 4) byone-way ANOVA. There
were many more transcripts that were up- or down-regulated
by at least twofold in 4-day samples than in 8 h samples
(Fig. 1B), consistent with the data shown in Fig. 1Af and g.
There were 79 transcripts showing more than twofold change
in expression; within this group, 31 had more than twofold
change detectable only at 8 h but not at day 4, 48 transcripts
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were regulated by more than twofold both at 8 h and at day 4
(Fig. 1B). However, 436 transcripts showed more than twofold
change only at day 4 but not at 8 h (Fig. 1B). Selected genes
belonging to these three categories (Rtwofold change at 8 h
only;Rtwofold change at day 4 only; andRtwofold change at
both time points) are summarized in Tables 3–5. Table 4
summarizes the partial list of 436 transcripts with more than
fourfold induction. The full list can be found in Supplementary
Table 1 (see supplementary data in the online version of the
Journal of Endocrinology at http://joe.endocrinology-jour-
nals.org/content/vol192/issue3/).
Since many genes related to junction remodeling have
previously been studied in the Adjudin model either by
RT-PCR or by immunoblotting, a comparison of the
expression levels of selected target genes from these experiments
versus the results of microarray experiment could assess the
reliability of these microarray data. Such genes are tabulated in
Table 2. Indeed, these microarray data illustrated that they
reproduced or recaptured the expression alterations of these
target genes earlier reported from this laboratory. For instance,
testin was shown to be induced drastically at day 4 with at least
6- to 15-fold and w50-fold increase in protein and mRNA
levels when detected by RIA and northern blots respectively
(Grima et al. 2001, Xia & Cheng 2005), and there was an almost
50-fold increase in mRNA level detected by microarray as
shown in Table 2. Other target proteins, such as N-cadherin,
b1-integrin, and TGF-b3, also yielded consistent results
between microarray and earlier RT-PCR and immunoblot
data (Table 2).
Expression profiling of the Adjudin-induced germ cell depletion
model based on microarray: data validations by quantitative real-
time PCR (qPCR), immunoblotting (IB), and immunohisto-
chemistry (IHC)
Genes with more than twofold change in their expression levels
were tabulated and grouped by their general functions (Tables
3–5). Among these are cytokines, transcription factors, kinases,
phosphatases, genes that regulate ion homeostasis and transport,
proteases, protease inhibitors, cell adhesion molecules, and
signaling molecules. These tables listed the top-ranked genes
from classifications defined in Fig. 1B and these top-ranked
Table 2 Fold changes in the steady-state mRNA levels of selected target genes in Adjudin-treated rat testes during Sertoli–germ cell AJ
restructuring which have been characterized in earlier studies
Time after Adjudin treatment (fold changes)
8 h Day 4
Target protein Array data Earlier study Array data Earlier study Reference
Protein group
AJ-integral mem-
brane proteins
N-CADHERIN 2.09 2.5 (IB) 2.45 4.5 (IB) Lee et al. (2004), Xia
& Cheng (2005)
NECTIN-3 1.01 – (IB) 0.72 0.25 (IB) Xia & Cheng (2005)
INTEGRIN-b1 1.82 2 (PCR) 1.5 (IB) 2.55 3.3 (PCR) 3-5.5
(IB)
Siu et al. (2003b), Xia
& Cheng (2005)
Adaptor proteins a-CATENIN 0.96 – (IB) 1.65 5 (IB) Xia & Cheng (2005)
b-CATENIN 1.12 2 (IB) 1.22 – (IB) Lee et al. (2003)
AXIN 0.92 – (IB) 0.92 0.5 (IB) Lee et al. (2004)
WASP 1.23 – (IB) 0.82 0.5 (IB) Lee et al. (2004)
ZYXIN 1.89 – (IB) 1.75 0.5 (IB) Lee et al. (2004)
p130CAS 1.0 2 (IB) 1.05 0.75 (IB) Siu et al. (2003b)
Protein kinases p38 MAPK 1.0 – (IB) 1.36 – (IB) Xia & Cheng (2005)
ERK1 0.9 – (IB) 1.42 2 (IB) Xia & Cheng (2005)
ERK2 0.96 – (IB) 1.1 2 (IB) Xia & Cheng (2005)
c-SRC 2.06 3 (IB) 1.213 – (IB) Lee & Cheng (2005)
ROCK1 3.17 2.5 (IB) 3.24 2 (IB) Lui et al. (2003a)
Actin-severing
protein
COFILIN 1.3 4 (PCR) 1.6 2 (PCR) Lui et al. (2003a)
Cytokine TGF-b3 1.2 2.5 (IB) 1.94 3 (IB) Xia & Cheng (2005)
Signaling proteins RhoB GTPase 1.66 2.5 (IB) 1.63 – (IB) Lui et al. (2003a)
TESTIN 2.2 2 (NB) 49.6 50 (NB) Cheng et al. (2001),
Grima et al. (2001)
Rab8B 1.17 – (IB) 1.04 0.5 (IB) Lau & Mruk (2003)
Proteases/ protease TIMP-2 1.21 1.5 (IB) 1.61 2.5 (IB) Siu & Cheng (2004)
inhibitors MMP2 0.88 – (IB) 1.59 0.9 (IB) Siu & Cheng (2004)
MMP9 0.71 – (IB) 0.87 – (IB) Siu & Cheng (2004)
IB, protein level detected by immunoblotting; PCR, steady-state mRNA level detected by RT-PCR; NB, steady-state mRNA level detected by northern blot;
numbers indicate fold change relative to control samples which were generated by comparing the densitometrically scanned data; –, no significant changes;
MMP, matrix metalloprotease; c-SRC, a non-receptor protein tyrosine kinase of the transforming gene of Rous sarcoma virus; TIMP, tissue inhibitor of
metalloprotease; ROCK, Rho-associated protein kinase 1, also known as Rhob; WASP, Wiskott–Aldrich syndrome protein.
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genes fell into the aforementioned functional groups, indicating
these genes are likely involved in the eventof germ cell depletion
from the seminiferous epithelium induced by Adjudin.
In the cytokine group, interleukin (IL) and chemokines are
most common in early and late time points after Adjudin
treatment. IL-1a and Cxcl10 showed strong induction by 8 h,
but their expression level receded by day 4 (Table 3). Cxcl12
and Il17re were only induced by day 4 (Table 4). Cxcl1, Ccl2,
and Cx3cl1 showed consistent up-regulation at both time
points (Table 5).
A number of transcription factors were significantly
induced after Adjudin treatment. Some were induced mostly
at 8 h, which included Egr1 and Egr2, Bhlhb2, and Jun
(Table 3). At day 4, Nupr1 and Pawr became significantly
up-regulated versus control (Table 4). Transcription factors,
Myc, Stat3, Atf3, and c-fos, also showed strong induction at
8 h and at day 4 (Table 5). Transcription factors that were
induced during Adjudin-induced germ cell loss from the
testis as shown in Tables 3–5 were summarized in Table 6
along with their known function in the testis, illustrating these
may be potential regulators of junction restructuring events at
the Sertoli–germ cell interface, pertinent to spermatogenesis.
Only a few genes displayed more than twofold reduction in
their expression levels by 8 h after Adjudin treatment, and
these include Camk2g, Th, and Btbd14b (Table 3). The
number of genes showing a reduced expression by 8 h or
4 days after Adjudin treatment was considerably less than
those displaying an increase in their expression (Tables 3–5,
Supplementary Table 1).
We selected a number of target genes to validate their
expression changes detected by microarray using other
methods as follows: (1) transcription factors: Stat3, Jun,
Bhlhb2, and c-fos (Fig. 2A and B); (2) cytokines and related
molecules: IL-1a, Cxcl10, and Tnfrsf1a (Fig. 2C); and (3)
proteases and protease inhibitors: Prss11 and Serping1
(Fig. 2D). The fold changes determined by qPCR were
consistent with microarray data for all nine genes selected for
analysis (Fig. 2 vs Tables 3–5). For instance, both Prss11 and
Table 3 Selected target genes with greater than twofold changes in their steady-state mRNA levels by 8 h after Adjudin treatment at the time of
extensive restructuring at the Sertoli–germ cell interface without the massive germ cell loss from the epithelium
Adjudin treatment
(fold changes)
Accession number Symbol 8 h Day 4 Description
Protein group
Cytokines NM_017019 Il1a 8.6 1.9 Interleukin 1a
U22520 Cxcl10 3.1 1.7 Chemokine (C-X-C motif) ligand 10
Transcription factors NM_012551 Egr1 8.5 1.5 Early growth response 1
NM_053633 Egr2 5.3 1.3 Early growth response 2
NM_053328 Bhlhb2 3.5 1.1 Basic helix-loop-helix domain
containing, class B2
BF407752 2.6 1.3 AT-rich interactive domain 1A
(Swi1-like; predicted)
BI288619 Jun 2.1 1.9 v-jun sarcoma virus 17 oncogene
homolog (avian)
Kinases/
phosphatases
NM_133578 Cpg21 3.1 0.6 MAP-kinase phosphatase (cpg21)
BE120425 Camk2g 0.4 0.6 Calcium/calmodulin-dependent protein
kinase II g
Cell adhesion
molecules
BF558056 Thsb2 4.2 1.6 Thrombospondin 2 (predicted)
AW141214 Itgav_predicted 2.6 1.5 Similar to integrin a subunit
(LOC296456)
AI177059 Mfap4_predicted 0.4 1.5 Microfibrillar-associated protein 4
(predicted)
Ion homeostasis
regulators
NM_053806 Kcnk6 2.8 1.9 Potassium channel, subfamily K,
member 6 (TWIK-2)
NM_031604 Atp6n1a 2.1 1.4 ATPase, HC transporting, lysosomal
non-catalytic accessory protein 1a
NM_012740 Th 0.3 0.6 Tyrosine hydroxylase
Signaling molecules BI288701 Btg2 3.9 1.3 B-cell translocation gene 2, anti-proliferative
BI284349 Myd116 3.5 1.7 Myeloid differentiation primary
response gene 116
BI294414 Spry1_predicted 3.4 1.6 Similar to sprouty 1 (LOC294981), mRNA
AI407755 Mesdc1_predicted 2.2 1.4 Mesoderm development candidate 1 (predicted)
NM_012580 Hmox1 2.1 1.6 Heme oxygenase; Heme oxygenase 1
AI598401 Pim1 2.0 1.2 Proviral integration site 1
NM_134413 Btbd14b 0.5 1.0 BTB (POZ) domain containing 14B
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Serping1 showed relatively little change at 8 h but were
induced by about four- to fivefold at day 4 (Table 4) in
microarray analysis, and results from qPCR showed that at
8 h, the steady-state mRNA levels of these two genes were
not significantly different from controls but were induced by
approximately fivefold at day 4 (Fig. 2D). Since these nine
genes were randomly selected from Tables 3–5 for analysis, it
is logical to conclude that the fold change detected for other
genes listed in these tables is reliable. Furthermore, the
changes in the steady-state mRNA levels of cytokines
reported in Tables 3–5, such as Cxcl1, were confirmed
using cytokine antibody array (data not shown).
Several additional target genes that were or were not listed in
the tables were also selected, and changes in their protein levels
Table 4 Selected target genes with greater than twofold changes in their steady-state mRNA levels by day 4 after Adjudin treatment at the time
of germ cell loss from the seminiferous epithelium
Adjudin treatment
(fold changes)
Accession number Symbol 8 h Day 4 Description
Protein group
Cytokines/receptors BF283398 Cxcl12 1.0 5.3 Chemokine (C-X-C motif) ligand 12
BM383766 Il17re 1.0 5.1 Similar to interleukin 17 receptor
E isoform 1
Transcription factors NM_053611 Nupr1 1.4 5.4 Nuclear protein 1
U05989 Pawr 1.3 4.1 PRKC, apoptosis, WT1, regulator
Ion homeostasis reg-
ulators
BG378926 S100a11_predicted 0.9 7.3 S100 calcium-binding protein A11
(calizzarin) (predicted)
BF401956 Trfr2_predicted 0.8 6.5 Similar to transferrin receptor protein 2
(TfR2) (LOC288562)
BF412731 Pdyn 1.0 6.2 Prodynorphin
NM_130741 Lcn2 1.2 5.9 Lipocalin 2
NM_053469 Hamp 2.0 4.9 Hepcidin antimicrobial peptide
NM_012733 Rbp1 1.2 4.1 Retinol-binding protein 1
Proteases/ protease
inhibitors
NM_031531 Spin2c 1.5 26.0 Serine protease inhibitor
NM_053819 Timp1 1.7 15.0 Tissue inhibitor of metalloproteinase 1
BF411331 Serpinb1a_predicted 0.9 6.8 Similar to serine (or cysteine) proteinase
inhibitor, clade B, member 1b
AW915763 Serping1 1.3 4.9 Serine (or cysteine) proteinase inhibitor,
clade G (C1 inhibitor), member 1,
(angioedema, hereditary)
NM_031721 Prss11 1.0 4.1 Protease, serine, 11
Cytoskeleton inter-
acting proteins
BI296155 1.6 5.6 Filamin, b, transcript variant 3
(Flnb) predicted
BE109711 Lcp1_predicted 1.1 4.8 Similar to lymphocyte cytosolic
protein 1 (LOC306071)
BM392410 Myh9 1.3 4.6 Myosin, heavy polypeptide 9
Cell adhesion
molecules
NM_133298 Gpnmb 1.6 13.6 Glycoprotein (transmembrane) nmb
Signaling molecules NM_133624 Gbp2 1.9 5.2 Guanylate-binding protein 2,
interferon-inducible
AW917760 1.3 7.9 Similar to myoferlin (Fer-1-like protein 3)
H31511 Trim2 1.5 6.0 Tripartite motif protein 2
(protein ubiquitination)
NM_019386 Tgm2 1.2 4.1 Tissue-type transglutaminase,
C polypeptide
BF282318 1.6 5.4 Similar to Bq135360 (LOC292922;
acute-phase response)
BM387864 1.8 5.3 Similar to FLI-LRR-associated protein-1
Y00480 RT1-Da 1.1 5.3 Rat MHC class II RT1, locus Da
BI285865 Tagln2_predicted 1.4 5.3 Similar to transgelin 2; SM22-a homolog
(LOC304983)
M25719 Pam 0.9 5.1 Peptidylglycine a-amidating
monooxygenase
BI274355 Olfml3_predicted 1.0 4.9 Olfactomedin-like 3 (predicted)
D88250 C1s 1.1 4.8 Complement component 1, s
subcomponent
BI285347 C4a 1.2 6.0 Palmitoyl-protein thioesterase 2
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were examined by IB and IHC. The cathepsin L (Ctsl) steady-
state mRNA level was shown to be induced by 2.5- and
3.1-fold by 8 h and 4 days respectively, by microarray (Table 5).
Consistent with these findings, the cathepsin L protein level
was shown to be stimulated by approximately two- and fivefold
by 8 h and 4 days respectively, by IB analysis (Fig. 3Aa). The
signals were also shown to be stimulated in IHC (Fig. 3Ab, c and
d). a2-Macroglobulin (a2-MG) was found to be induced by
1.1-fold at 8 h and threefold at day 4 (Supplementary
Table 1), and this pattern of induction was consistent with
the IB and IHC data (Fig. 3B). The testin steady-state
mRNA level was induced by approximately twofold at 8 h
and w50-fold at day 4 (Tables 2 and 5), with its protein
level induced by approximately sixfold at day 4 (Table 2 and
Fig. 3Ca). These results are also consistent with data
obtained by IHC (Fig. 3Cd versus Fig. 3Cbc). Changes in
the expression of a tight junction integral membrane
protein, claudin 3, were also examined. For example,
claudin 3 displayed no change in protein level and
distribution after Adjudin treatment (Fig. 3D). These results
were consistent with microarray data, which showed no
significant changes on claudin 3, claudin 1, and occludin
Table 5 Selected target genes with greater than twofold changes in their steady-state mRNA levels by 8 h and day 4 after Adjudin treatment
Adjudin treatment
(fold change)
Accession number Symbol 8 h Day 4 Description
Protein group
Cytokines/receptors NM_030845 Cxcl1 62.6 6.8 Chemokine (C-X-C motif) ligand 1
NM_031530 Ccl2 8.1 5.2 Chemokine (C-C motif) ligand 2
NM_017020 Il6r 4.0 8.1 Interleukin 6 receptor
BI303379 Tnfrsf12a 3.8 8.4 Tumor necrosis factor receptor
superfamily, member 12a
NM_134455 Cx3cl1 3.2 5.3 Chemokine (C-X3-C motif) ligand 1
NM_030997 Vgf 3.0 16.1 VGF nerve growth factor inducible
NM_013091 Tnfrsf1a 2.2 6.1 Tumor necrosis factor receptor
superfamily, member 1a
Transcription factors BF415939 c-fos 26.8 3.5 c-fos oncogene
NM_012912 Atf3 15.1 11.2 Activating transcription factor 3
AI716248 3.4 4.9 Similar to RIKEN cDNA 9230117N10
(LOC361749), nucleus protein
(predicted)
NM_012591 Irf1 2.1 4.1 Interferon regulatory factor 1
NM_012603 Myc 2.1 2.7 v-myc avian myelocytomatosis viral
oncogene homolog
BE113920 Stat3 2.0 2.6 Signal transducer and activator of
transcription 3
Cell adhesion
molecules
AI406660 Thbs1 6.0 2.4 Thrombospondin 1
BE110753 Itga6 3.3 3.6 Integrin a6
AI408095 Smagp 2.9 4.6 Small cell adhesion glycoprotein
Proteases NM_013151 Plat 2.8 3.1 Plasminogen activator, tissue type
AI232474 Ctsl 2.5 3.1 Cathepsin L
Transporters NM_012532 Cp 2.7 4.2 Ceruloplasmin
NM_031325 Ugdh 2.6 3.6 UDP-glucose dehydrogenase
NM_053318 Hpx 4.0 46.2 Hemopexin
Signaling molecules AI176519 Ler3 9.7 4.3 Immediate early response 3
AA800587 Gpx2 2.8 7.0 Glutathione peroxidase 2
BF420334 Rab20_predicted 2.7 2.5 Similar to rab20 (LOC364641) mRNA
AI703807 Crim1_predicted 2.3 5.9 Cysteine-rich motor neuron 1 (predicted)
AA901350 2.3 5.9 Guanylate nucleotide-binding protein 3
(predicted)
U16858 Testin 2.2 49.6 Testin
BE099056 Grtp1_predicted 2.2 3.0 Similar to GH-regulated TBC protein 1
(LOC361180), mRNA
BF412519 Ripk2_predicted 2.2 4.1 Receptor (TNFRSF)-interacting
serine–threonine kinase 2 (predicted)
NM_054008 Rgc32 2.1 2.8 Response gene to Complement 32
(cyclin-dependent kinase regulation)
BE113215 Trim47_predicted 2.1 4.0 Tripartite motif protein 47
(predicted; protein ubiquitination)
BI294994 Optn 2.1 2.5 Optineurin
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Table 6 Summary of transcription factors that are significantly induced during Adjudin-induced anchoring junction restructuring in the testis
Other names KO phenotype Function Studies in testes References
Transcription factors
Egr1 NGFI-A/Krox-
24/zif/268
Female infertile;
male fertile or
sterile
Regulates LH-b expression Cultured Sertoli cells;
Leydig cells
Lee et al. (1996), Topilko et al. (1998),
O’Donovan et al. (1999)
Egr2 Krox-20 Perinatal
lethality
Brain development n.k. Schneider-Maunoury et al. (1993), Swiatek
& Gridley (1993)
Bhlhb2 SHARP-
2/Stra13/DEC1
Normal, aging
mice develop
autoimmune
disease
Transcription repressor; required for cyto-
kine production; activated by TGF-b
n.k. Sun et al. (2001), Zawel et al. (2002)
Jun n.a. Embryonic-
perinatal
lethality
Multiple functions; JNK signaling; stage-
specific expression
Spermatogonia, pre-
leptotene sperma-
tocytes
Alcivar et al. (1990), Johnson et al. (1993),
Schultz et al. (1995)
Nupr1 Nuclear protein p8 Normal; increased
sensitivity to lipo-
polysaccharide
Enhances TGF-b1-smad signaling n.k. Mallo et al. (1997), Garcia-Montero et al.
(2001), Vasseur et al. (2003)
Pawr Par-4 Splenomegaly Transcription corepressor; mediates TNFa-
induced apoptosis
n.k. Garcia-Cao et al. (2003), Lafuente et al.
(2003), Sushma Gurumurthy (2004),
Goswami et al. (2006)
c-fos n.a. Reduced viability
and size, impaired
gametogenesis
Regulates Sertoli cell differentiation on
basement membrane; stage-specific
expression
Cultured Sertoli cells Johnson et al. (1992) Papadopoulos & Dym
(1994), Schultz et al. (1995),
Milde-Langosch (2005)
Atf3 LRF-1/LRG-21/CRG-
5/ TI-241
Normal Stress response n.k. Hai & Hartman (2001), Hartman et al.
(2004)
Irf1 n.a. Normal Regulates interferon expression Cultured Sertoli cells Matsuyama et al. (1993), Tanaka &
Taniguchi (2000), Sato et al. (2001)
Myc n.a. Embryonic lethality;
heterozygous
females with
reduced fertility
Multiple functions; testosterone and FSH
induce c-Myc expression in cultured
Sertoli cells
Spermatogonia Koji et al. (1988), Davis et al. (1993), Lim
et al. (1994), Lim & Hwang (1995)
Stat3 n.a. Embryonic lethality Multiple functions; regulates IL-6 and IFN-
g mediated gene expression in Sertoli
cells
Cultured Sertoli cells Jenab & Morris (1997), Takeda et al.
(1997), Takeda & Akira (2000)
KO, knockout, n.a, not applicable; n.k, not known.
W
X
IA
an
d
o
th
ers
.
Ju
n
ctio
n
d
yn
am
ics
an
d
sp
erm
ato
gen
esis
5
7
4
Jo
u
rn
al
o
f
En
d
o
crin
o
lo
gy
(2
0
0
7
)
1
9
2
,
5
6
3
–5
8
3
w
w
w
.en
d
o
crin
o
lo
g
y-jo
u
rn
als.o
rg
AUTHOR COPY ONLY
after Adjudin treatment (data not shown; see raw data in
GEO depository). However, other tight junction (TJ)
proteins displayed significant changes at day 4. For instance,
JAM-A and claudin 11 showed a w1.8-fold increase in
expression at day 4 (but no change at 8 h), and claudin 4
expression level was reduced by as much as 50% at day 4
(data not shown; see raw data in GEO depository). These
results also illustrate the expression of different TJ proteins
were differentially regulated.
Clustering analysis to identify genes that are closely regulated
We performed unsupervised hierarchical clustering of the
eight samples (Ctrl (nZ3), 8 h (nZ2), and day 4 (nZ3))
and the 1466 transcripts using the GeneSpring software and
the results were summarized in Fig. 4. The branches of the
dendrogram were removed from this presentation, but
the main subtrees were illustrated by a line showing five
different domains (Figure 4a–e), which were again classified
into two larger subtrees of i and ii. This clustering analysis
grouped similarly regulated genes. Two representative regions
in the dendrogram were selected and examined in detail in
Fig. 4B and C, which showed the induced expression of these
genes at day 4 but not at 8 h, and reduced expression at 8 h
but mildly increased expression at day 4 respectively.
Identifying and ranking signaling pathways activated by Adjudin
in the testis
We next used Pathway Express (PE) to identify the signaling
pathways that were activated during Adjudin-induced germ cell
loss from the epithelium (Draghici et al. 2003a,b, Khatri et al.
2004, 2005; Table 7). PE is a tool in the Onto-Tools ensemble
(Wayne State University, see http://vortex.cs.wayne.edu (Dra-
ghici et al. 2003a,b, Khatri et al. 2004, 2005)) that was designed to
identify the signaling pathways that contain the corresponding
target genes. A list of genes with their fold changes were first
submitted to the system, which then performed a search and
built a list of all associated pathways. The system calculated an
impact factor to rank the pathways based on the importance of a
gene in the pathway (indicating how much it affects the
downstream signaling), the strength or fold of change of the
gene, and percentage of genes in the pathway that were included
in this list of genes (Khatri et al. 2004, 2005). The probe set ID
number with the corresponding fold changes at 8 h or at day 4
were tabulated (all 1466 probe sets) and imported into the
program and the top signaling pathways were identified. At 8 h,
the top-ranking pathways identified based on the impact factor
were phosphatidylinositol (PI) signaling (7/43: input genes/
pathway genes), focal adhesion (13/109), cytokine–cytokine
receptor interactions (16/110), MAPK signaling pathway
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(21/153), tight junction (10/185), apoptosis (11/66), and
calcium signaling pathway (13/161; Table 7). At day 4, the
top-ranking pathways were phosphatidylinositol signaling, focal
adhesion, cytokine–cytokine receptor interactions, tight junc-
tion, MAPK signaling pathway, apoptosis, and calcium signaling
pathway (Table 7). The numbers of input and pathway genes for
8 h and day 4 were the same. Collectively, these results were
consistent with recently published findings that these are
putative signaling pathways that regulate Sertoli–germ cell
adhesion (Lui et al. 2003a, Siu et al. 2003b, 2005, Wong et al.
2005, Xia & Cheng 2005, Zhang et al. 2005) and probably
suggest that these are the most important signaling events taking
place in the testis after the rats were treated with Adjudin.
Discussion
Junction restructuring during spermatogenesis is a complex process
regulated by a multitude of molecules
This microarray study has identified genes that are
differentially regulated during Adjudin-induced AJ restruc-
turing at the Sertoli–germ cell interface prior to the massive
physical dislodging of germ cells, at 8 h vs day 4, when
virtually all elongating/elongate spermatids and most round
spermatids and spermatocytes were depleted from the
epithelium, and compared with normal testes. Among these
genes, we summarize those with most drastic induction in the
steady-state mRNA level versus controls and categorize them
into functional groups (Tables 3–5). Although only the
expression data were obtained using this genome-wide gene
profiling approach without considering translational and
post-translational regulations, these genes nonetheless are
potentially key players in the junction restructuring events at
spermatogenesis since recent studies using specific inhibitors
and the other models involving steroid implants to suppress
endogenous testosterone level in the testis have clearly
demonstrated that data obtained from this model is relevant
to the in vivo physiology of Sertoli–germ cell interactions,
particularly cell adhesion regulation (Lui et al. 2003a, Siu et al.
2003b, 2005, Siu & Cheng 2004, Lee & Cheng 2005, Lee
et al. 2005, Wong et al. 2005, Xia & Cheng 2005). The
identified genes include those that are involved in signaling
and/or regulatory functions pertinent to the junction
restructuring: (1) cell–cell communication, including cyto-
kine-mediated signaling, ion transport and homeostasis;
(2) intracellular signaling mediated via kinases, phosphatase,
and adaptors; (3) structurally important cell adhesion and
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Figure 3 A study by immunoblotting and immunohistochemistry to assess changes in selected target proteins in rat testes after Adjudin
treatment to validate microarray results. (A; a) Immunoblot analysis of cathepsin L in control (Ctrl), 8-h and 4-day rat testes. (b–d)
Immunohistochemistry localization of cathepsin L in control, 8-h and 4-day testis respectively. Bar in bZ70 mm, also applies to (c–d), as well
as (b–d) in (B), (C) and (D). (B–D) Corresponding immunoblot analysis and immunohistochemistry results for a2-macroglobulin (a2-MG),
testin, and claudin 3 respectively, similar to those shown in (A). The induction of testin during Adjudin-induced germ cell loss from the testis is
consistent with earlier reports (Grima et al. 1997, Cheng et al. 2001), but changes of a2-MG and cathepsin or the unresponsiveness of claudin
3 have not been reported.
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cytoskeleton-related proteins; (4) proteases and protease
inhibitors that affect cell matrix, cell–cell and intracellular
interactions; and (5) transcription factors. Except for the last
group and ion transport/homeostasis proteins, genes belong-
ing to all other groups have been investigated and shown to be
involved in regulating junction restructuring in earlier studies
(Mruk & Cheng 2004b). We had since proposed a junction
restructuring theory to describe the mechanisms of germ cell
movement in the seminiferous epithelium (Mruk & Cheng
2004b). This theory was formulated based on studies of in vivo
(e.g. Adjudin model, cadmium model), and in vitro (e.g.
Sertoli–germ cell co-cultures) which have also identified
several putative signaling pathways that are known to regulate
Sertoli–germ cell adhesion (Lui et al. 2003a, Siu et al. 2003b,
Lee et al. 2005), which are also confirmed in this microarray
study. Perhaps the most important of all, results of this gene
profiling study have unraveled two important lines of research
pertinent to Sertoli–germ cell adhesion regulation. First,
additional mechanistic pathways that can be potentially
crucial to Sertoli–germ cell adhesion have been identified.
For instance, this gene profiling study has demonstrated that
PI-3 kinase, FAK, and MAPK are the leading signaling
molecules that are involved in the Adjudin-induced Sertoli–
germ cell AJ restructuring, confirming results of earlier
studies (Lui et al. 2003a, Siu et al. 2003b, 2005, Wong et al.
2005, Xia & Cheng 2005, Zhang et al. 2005, Xia et al. 2006).
However, cytokine–cytokine receptor interactions, besides
TGF-b3, TNFa, and their corresponding receptors, IL-1a
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Figure 4 Hierarchical clustering of 1466 differentially regulated transcripts in rat testes from eight samples (nZ3 for control (Ctrl) testes, nZ2
for 8 h, nZ3 for day 4 following Adjudin treatment). (A) Expression fold changes are depicted by the color map in the left panel. The
dendrogram in the right panel illustrates that these 1466 probe sets displayed consistent patterns of up- or down-regulation by 8 h or 4 days
after Adjudin treatment versus controls. Note that these patterns are consistent across different chips using different batches of samples within
the same group. Five domains can be identified (a–e) that comprise the entire spectrum, which are also the five subtrees in the dengrogram
(branches were removed without distracting the main diagram). These domains can be further grouped into two categories of i and ii, the
subtrees at a higher level, which show a more pronounced mRNA induction at day 4 than 8 h (i) and vice versa (ii). Two boxed areas shown in
(A) were selected and examined in detail and shown in (B) (top panel) and (C) (bottom panel). (B) Selected genes with significantly increased
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and its receptors, have been identified to be a crucial
mechanism to AJ dynamic regulation. This suggests that an
array of cytokines produced by Sertoli and germ cells into the
microenvironment at the seminiferous epithelium such as the
blood – testis barrior, are working in concert to activate their
receptors in tandem to regulate junction restructuring events
pertinent to spermatogenesis. Furthermore, the calcium
signaling pathway and apoptosis regulatory genes are both
activated, which should be carefully evaluated in future
studies. Secondly, a set of transcription factors have now been
identified, some of which can potentially regulate TJ and/or
AJ dynamics, which should be carefully evaluated in future
studies. It will also be crucial in future studies to examine if
the downstream action of PI-3 kinase, FAK, and MAPK are
mediated via one or several of these transcription factors.
Does the Adjudin model reveal physiologically relevant
information on the biology of spermatogenesis?
Besides building expression profiles of thousands of genes in the
testis, results from this microarray study could be used to identify
genes pertinent to other testicular function. Indeed, many
transcripts were found to be significantly induced after multiple
rounds offiltering. We did not explore the potential functions of
these ‘new’ genes in this study but they are summarized in
Supplementary Table 2 (http://joe.endocrinology-journals.
org/content/vol192/issue3/). At present, a number of
expression profile studies in the testis are available in the
literature (Schlecht et al. 2004, Small et al. 2005, Zhou et al.
2005) pertinent to development, spermatogenesis, and/or
fertility regulation. The present study, however, uses an
exogenic compound and examines its effect in the testicular
gene expression during the time course of germ cell loss with
extensive restructuring at the Sertoli–germ cell interface. An
important question remains to be addressed: does this drug
model reveal the molecular targets pertinent to
spermatogenesis?
The approach of using the Adjudin model to identify
molecular targets pertinent to junction remodeling during
spermatogenesis may be criticized that the changes in the
expression of multiple genes are the results of drug toxicity.
However, recently completed toxicity studies have shown that
the dose used in the present study that was effective to induce
germ cell loss had no toxic effects in rats or mice (Cheng et al.
2005, Mruk et al. 2006). Moreover, Adjudin-induced germ cell
depletion is reversible (Cheng et al. 2001, Grima et al. 2001).
The Adjudin effects on a numberof genes seemingly support the
notion that this model offers a snapshot of expression alterations
that represent their changes during spermatogenesis. For
instance, cathepsin L becomes highly expressed at stages VII–
VIII (Erikson-Lawrence et al. 1991, Anway et al. 2004), which
coincides with spermiation and BTB restructuring, and is also
induced during Adjudin-induced germ cell loss from the
epithelium, mimicking the cellular events of spermiation. TGF-
b3,which was shown to disrupt both Sertoli–germ cell adhesion
and BTB integrity and was known to be stage-specificallyTa
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regulated with the highest expression at stages VI–VIII (Xia &
Cheng 2005, Xia et al. 2006), is also induced after Adjudin
treatment at the time of germ cell loss, possibly because of AJ
restructuring and this observation is consistentwith the results of
an earlier report (Xia & Cheng 2005).
Thus, we hypothesize that the Adjudin-induced restructur-
ing at the Sertoli–germ cell interface mimics the anchoring
junction restructuring events in the epithelium during
spermatogenesis. This postulate was supported by recent
findings that the signaling molecules crucial to Sertoli–germ
cell AJ dynamics as identified using the Adjudin model, such as
p-FAK, p-c-Src, rMTMR2, and pERK (Li et al. 2000, Siu et al.
2003b, 2005, Xia & Cheng 2005) have also been found in
another in vivo model using androgen/estrogen implants to
suppress the intratesticular androgen level which is known to
perturb Sertoli–spermatid adhesion in adult testes (O’Donnell
et al. 2000, Wong et al. 2005, Xia et al. 2005b, Zhang et al.
2005). This is plausibly due to the fact that there are only a
limited number of signaling pathways and molecular
mechanisms that control a specific phenotype. For instance,
if classified by the types of cell surface receptors involved, the
number of signaling pathways in human cells can be as small as
16, and as many as 200 only if counting all the variants of
receptors (Fishman & Porter 2005). Normal spermatogenesis
and the Adjudin-induced germ cell depletion model share
some phenotypic features, such as junction restructuring, and
it is not unusual that they utilize similar signals and/or
regulatory mechanisms. This hypothesis should be carefully
evaluated in future studies. Likewise, results using Pathway
Express to rank the top signaling pathways that were activated
by Adjudin in testes also support this postulate. Lipid and
protein kinases, such as PI-3 kinase, are important transducers
to relay signals from matrix to cells, regulating cytoskeletal
remodeling, and cell migration (Carragher & Frame 2004,
Webb et al. 2004). It is not surprising to find that
phosphatidylinositol signaling and focal adhesion kinase
signaling were the top two pathways. Indeed in studies using
the Adjudin model, Sertoli–germ cell co-cultures, and the
androgen-suppression model have shown that integrin b1,
PI-3 kinase, and its downstream protein kinases are crucial
regulators of restructuring at the apical ES (Siu et al. 2003b,
2005, Wong et al. 2005). Additionally, MAPKs have also been
identified in earlier studies as important regulators of junction
dynamics in the testis (Lui et al. 2001, 2003b,c, Wong et al. 2004,
Wong & Yan Cheng 2005, Xia & Cheng 2005, Xia et al. 2005a,
2006). Taken collectively, these results provide strong evidence
that the Adjudin model is useful to study the junction
restructuring events pertinent to spermatogenesis.
Molecular signatures for the regulation of junction restructuring
during spermatogenesis
It is of interest to note that junction restructuring and migration
of different cell types share similar underlying regulatory
mechanisms, since these events are fundamentally conserved
across species and cell types regarding the molecules that are
involved in these cellular processes. For instance, results from
this study have pinpointed the important players in these events
in the testis (Tables 3–5). Unsurprisingly, these results were in
agreement with other genomic-scale profiling studies which
have also identified genes belonging to kinases, proteases, cell
adhesion molecules, and cytokine signalings are enriched in
migratory cells (Borghese et al. 2006, Wang et al. 2006). We
herein discuss target gene groups identified in this Adjudin
model, which may be crucial to junction remodeling during
germ cell migration.
Cytokines and cytokine receptor signalings
Besides TGF-b3 (Xia & Cheng 2005), Adjudin indeed activated
the expression of several cytokines and chemokines in adult rat
testes. ILs and chemokines are typically involved in inflammatory
responses and they are also crucial to T-cell migration (Petersen
et al. 2006). Other studies have shown that cytokines are
important players of immunological responses in the testis after
stress or injury (Hedger & Meinhardt 2003). However, as no
macrophage infiltration in the testis was observed after Adjudin
treatment, it is logical toconclude that the inflammation response
to Adjudin is probably a negligible possibility. The activation of
multiple cytokines and chemokines at the time of germ cell loss
implies that these paracrine/autocrine factors are involved in the
signaling cascades that lead to the restructuring at the Sertoli–
germ cell interface. For instance, IL-1a is a pro-inflammatory
cytokine but in the testis it is also secreted by Sertoli cells in the
absence of local inflammation (Sultana et al. 2004). An IL-1a
isoform was found to be secreted bidirectionally to the
interstitium and intratubular compartment (Sultana et al.
2004). As a paracrine factor, it regulates Leydig cell steroidogen-
esis with age-dependent effects (Sultana et al. 2004). By 8 h after
Adjudin treatment, a drastic induction (8.6-fold) of IL-1a was
detected, which strongly suggests that its early response signifies
its significance in AJ restructuring, which should be investigated
in future studies.
Cx3cl1 (or fractalkine) is also expressed in Leydig cells,
Sertoli cells, and spermatogonia and it is believed to be
regulating cell–cell interactions in and out of the seminiferous
tubules and other epithelia (Rossi et al. 1998, Habasque et al.
2003). In the Adjudin model, a 3.2- and 5.3-fold increase in
expression at 8 h and at day 4 respectively, were detected. Vgf
(VGF nerve growth factor inducible) was found to be highly
induced after Adjudin treatment (3- and 16-fold increase at 8 h
and at day 4 respectively), although its basal expression level in
the rat testis was relatively low (raw signal intensity atw30).
There is no literature on Vgf in the testis, since Vgf is a neuron-
secreted polypeptide, particularly abundant in adult
hypothalamus. VgfK/K mice were found to be small,
hypermetabolic, hyperactive, and infertile for both males and
females (Hahm et al. 1999), which is likely the result of a
reduced production of pituitary gonadotropin hormones
(Hahm et al. 1999), which in turn, affected spermatogenesis
in the testis. In short, these cytokines should be examined
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closely to determine if they play any role in Sertoli–germ cell
AJ restructuring during spermatogenesis.
Proteases and protease inhibitors
Cathepsin L and tissue-type plasminogen activator (tPA) are
known to be expressed stage specifically in the testis (Vihko
et al. 1989, Chung et al. 1998). Cathepsin L and urokinase-type
plasminogen activator (uPA) are also induced in the cadmium
model (Wong et al. 2004), supporting the notion that they take
part in the regulation of junction restructuring. Similarly, tissue
inhibitor of metalloproteases 1 (TIMP-1) was also found to
regulate BTB and AJ dynamics (Mruk et al. 2003, Siu et al.
2003a), but its activation in the Adjudin model has not been
reported until now (see Table 4). The function of other
proteases and protease inhibitors, such as Prss11 and Serping1,
in these events are not known. For instance, no reports are
found in the literature regarding the expression of Spin2c or
Serping1 by the testis, but they are highly induced after Adjudin
treatment (Table 4). It will be of interest to examine the
regulation of these proteins in the testis during the epithelial
cycle and their role in AJ restructuring.
Transcription factors
Transcription factors that were induced by Adjudin in the testis
were summarized in Table 6. For example, early growth
responses 1 and 2 (Egr1 and Egr2) were greatly induced 8 h after
Adjudin treatment (Table 3). They belong to the Egr family of
zinc-finger transcription factors, which are known to be
involved in cellular growth and differentiation (Hofmann et al.
2005, Oatley et al. 2006). Another gene in the same family,
Egr4 is also essential for spermatogenesis. Male Egr4 null mice
were infertile because most of the germ cells underwent
apoptosis at the early-mid pachytene spermatocyte stage
(Tourtellotte et al. 1999). The involvement of these
transcription factors in junction restructuring in the testis
should be closely examined in future studies.
Signaling molecules
A large number of signaling molecules were found to be
induced after Adjudin treatment. Although it is still difficult to
put them in context with the regulation of cellular events at
the Sertoli–germ cell interface, these findings, nonetheless,
have provided new leads for future research. For example,
Crim1 (cysteine-rich motor neuron 1) was found to be
activated by 2.3-fold at 8 h and 5.9-fold at day 4 (Table 5).
Crim1 was originally identified in the developing nervous
systems in vertebrates (Kolle et al. 2000). This protein was
activated during murine gonad development and expressed
strongly in Sertoli cells (Georgas et al. 2000). It functions to
antagonize bone morphogenic proteins, and possibly TGF-bs
(Georgas et al. 2000). It is not known if adult testes also
express Crim1 but the signal intensity of Crim1 detected by
microarray was comparable with that of TGF-b3 in control
testes (175 vs 135), indicating Crim1 indeed is expressed in
adult testes. Since TGF-b superfamily genes play essential
roles in testicular development and function (Skinner 1993,
Gnessi et al. 1997, Shimasaki et al. 2004, Xia et al. 2005a), the
identification of a new regulator of this superfamily is of great
interest in future studies to examine their interacting
physiological roles in maintaining spermatogenesis and
testicular function.
Summary and conclusion
This microarray profiling study has identified different target
genes belonging to several functional groups that may be
important for the regulation of junction restructuring during
spermatogenesis. Some of these genes highlighted herein
merit additional research to delineate their role and
involvement in spermatogenesis.
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